Meta Pixel

News and Announcements

Wizard Power building a global solar project pipeline

  • Published November 19, 2012 6:31PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Canberra based Concentrating Solar Power (CSP) technology developer, Wizard Power, has obtained its first commercial power project and has a pipeline of another 4 Gigawatts of project opportunities globally.

Wizard Power, which was formed in 2005 to commercialise CSP technology developed at the Australian National University, is part of the SolarOasis Consortium which will use Wizard Power’s Big Dish solar thermal concentrator for a 40 megawatt solar power project to be built at Whyalla in South Australia.

That project, which will initially use 300 mirrored Big Dishes, has the potential to increase in size significantly over time. The project has attracted $60 million in federal government funding.

Wizard Power’s business model is to develop the CSP technology and license its intellectual property to project developers around the world.

“We have received significant international interest in our technology and are talking with developers about projects which together add up to over 4 Gigawatts,” said Wizard Power’s Lisa Robey.

Wizard Power will produce the mirrors used in the solar dishes and is establishing a factory facility in the ACT.

Lisa Robey said Wizard Power was in the middle of a two-phase $10 million capital raising, part of which will be used to develop the mirror factory.

She said the company’s plan was to proceed to an IPO, but would not rule out a trade sale.

“There has been some significant trade sales in our sector so we would not rule that out, but our focus at this stage is an IPO,” she said.

Wizard Power will be presenting at the Wholesale Investor Emerging Companies showcase, to be held in Sydney on Tuesday November 20 and the Wholesale Investor Emerging Companies showcase, to be held in Melbourne on Thursday November 22 .

Company Updates
Dogs First to Reduce Risk: QBiotics’ Smarter Path to Oncology Markets

QBiotics took a compound derived from a north Queensland rainforest tree all the way to veterinary registration before pursuing human oncology to de-risk its human cancer programme. Interim CEO Ebru Davidson argues that sequence – now backed by early responses across several human cancers – is the company’s real asset. The story that pulled Wholesale […]

Company Updates
Built on discipline, not complexity: inside an ASX equities income strategy

Haydn Froggatt and Zac Brabin have decades of derivatives experience between them and access to almost any strategy in the market. They use two of the simplest structures available, and wrote 202 positions with them last year. Published by Fairway Capital Management. Based on an interview with co-founders Haydn Froggatt and Zac Brabin. Two traders, […]

Join over 45,000+ sophisticated investors

Join Now